These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3350527)

  • 1. Hand steadiness: effects of sex, menstrual phase, oral contraceptives, practice, and handgun weight.
    Hudgens GA; Fatkin LT; Billingsley PA; Mazurczak J
    Hum Factors; 1988 Feb; 30(1):51-60. PubMed ID: 3350527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in insulin receptors during oral contraception.
    De Pirro R; Forte F; Bertoli A; Greco AV; Lauro R
    J Clin Endocrinol Metab; 1981 Jan; 52(1):29-33. PubMed ID: 7451643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alcohol use, negative mood states, and menstrual cycle phases.
    Sutker PB; Libet JM; Allain AN; Randall CL
    Alcohol Clin Exp Res; 1983; 7(3):327-31. PubMed ID: 6353985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on psychophysiological performance in female athletes during menstruation without and with hormonal contraceptives].
    Stecher VH; Beyer L
    Med Sport (Berl); 1986; 26(8):252-4. PubMed ID: 12315369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A direct immunoradiometric assay for human plasma prorenin: concentrations in cycling women and in women taking oral contraceptives.
    Schumacher M; Nanninga A; Delfs T; Mukhopadhyay AK; Leidenberger FA
    J Clin Endocrinol Metab; 1992 Aug; 75(2):617-23. PubMed ID: 1639960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in pure-tone thresholds and temporary threshold shifts as a function of menstrual cycle and oral contraceptives.
    Swanson SJ; Dengerink HA
    J Speech Hear Res; 1988 Dec; 31(4):569-74. PubMed ID: 3230886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurohypophysial hormone and melatonin secretion over the natural and suppressed menstrual cycle in premenopausal women.
    Kostoglou-Athanassiou I; Athanassiou P; Treacher DF; Wheeler MJ; Forsling ML
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):209-16. PubMed ID: 9828909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The secretion of human chorionic gonadotropin-like substance in women employing contraceptive measures.
    Huang SC; Chen HC; Chen RJ; Hsieh CY; Wei PY; Ouyang PC
    J Clin Endocrinol Metab; 1984 Apr; 58(4):646-53. PubMed ID: 6699130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication.
    Yonkers KA; Kando JC; Cole JO; Blumenthal S
    Am J Psychiatry; 1992 May; 149(5):587-95. PubMed ID: 1575248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal factors and the laboratory detection of Chlamydia trachomatis in women: implications for screening?
    Crowley T; Horner P; Hughes A; Berry J; Paul I; Caul O
    Int J STD AIDS; 1997 Jan; 8(1):25-31. PubMed ID: 9043977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lynestrenol 1 mg.-mestranol 0.1 mg: a new low dose oral contraceptive: a clinical study.
    Kamal I; Hefnawi F; Younis N
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):11-5. PubMed ID: 12254506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in the adaptation of glucose metabolism to short-term fasting: effects of oral contraceptives.
    Corssmit EP; Stouthard JM; Romijn JA; Endert E; Sauerwein HP
    Metabolism; 1994 Dec; 43(12):1503-8. PubMed ID: 7990703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Auditory sensitivity and tone-sequence reproduction in oral contraceptive users and nonusers.
    Grieze-Jurgelevicius DM; Chernos TN; Petersik JT
    Percept Mot Skills; 1990 Feb; 70(1):271-8. PubMed ID: 2326127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of lactation and return of menstruation in lactating women using hormonal contraception and IUDs.
    Prema K
    Contracept Deliv Syst; 1982 Jan; 3(1):39-46. PubMed ID: 12264126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menstrual blood loss during oral contraceptive therapy and in IUD users.
    Hefnawi F; Younis N; Zaki K; Rassik SA; Mekkawi T
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):1-4. PubMed ID: 12254505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
    Lemay A; Dewailly SD; Grenier R; Huard J
    J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic clearance rates of luteinizing hormone in women during different phases of the menstrual cycle and while taking an oral contraceptive.
    Wehmann RE; Blackman MR; Harman SM
    J Clin Endocrinol Metab; 1982 Oct; 55(4):654-9. PubMed ID: 7107812
    [No Abstract]   [Full Text] [Related]  

  • 19. Masking effect of hormonal contraceptives on discriminating quantitative features of visually normal intermediate cells in positive and negative cervical smears.
    Kwikkel HJ; Boon ME; van Rijswijk MM; Rietveld WJ; Stolk JG
    Anal Quant Cytol Histol; 1986 Sep; 8(3):227-32. PubMed ID: 3778614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing menstrual disturbances.
    Barnett B
    Netw Res Triangle Park N C; 1995 Jun; 15(4):8. PubMed ID: 12289833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.